EyeBrain

EyeBrain, founded in 2008 and headquartered in France, is at the forefront of developing and manufacturing medical devices aimed at the early diagnosis of neurological diseases. Specializing in Biotechnology, Manufacturing, and Medical Devices, the company has positioned itself as a key player in the neurological diagnostic space.

Their flagship product, EyeBrain Trackers, is a medical eye tracker technology that aids neurologists in diagnosing and monitoring the progression of conditions like Parkinson plus syndromes. This innovative approach not only supports more accurate patient assessments but also enhances treatment efficacy by allowing for precise disease monitoring.

The company received its latest funding of $1.47M through a Venture Round on 03 February 2015, with the investment led by Anaxago. EyeBrain's continuous focus on innovation and its strong foundation in the medical domain make it a compelling candidate for investors interested in the intersection of healthcare technology and biotechnology.